Ascletis Pharmaceuticals

Ascletis doses healthy subjects in Phase I trial of oral Covid-19 tablets
Clinical Trials Arena
Mon, 10/10/22 - 10:43 am
Ascletis Pharmaceuticals
clinical trials
COVID-19
ASC10
Gannex received US IND approval for its NASH Drug Candidate ASC42
Pharmaceutical Business Review
Mon, 10/12/20 - 10:05 am
Gannex Pharma
Ascletis Pharmaceuticals
NASH
FDA
ASC42
Ascletis poaches top MSD China executive as its new R&D chief
Fierce Biotech
Sat, 03/2/19 - 12:43 pm
R&D
China
Ascletis Pharmaceuticals
Ascletis Acquires Rights to PH II NASH Candidate
CP Wire
Thu, 02/14/19 - 12:14 am
NASH
Ascletis Pharmaceuticals
3-V Biosciences
Ascletis Acquires Rights to PH II NASH Candidate
Wed, 02/13/19 - 05:02 pm
Ascletis Pharmaceuticals
3-V Biosciences
Roche in hepatitis C drug deal with Ascletis in China
Reuters
Mon, 04/15/13 - 09:39 am
Roche
China
Ascletis Pharmaceuticals
hepatitis C
Pegasys
Alnylam Inks Oncology Deal - Analyst Blog
NASDAQ
Sun, 07/15/12 - 12:11 pm
Alnylam
Ascletis Pharmaceuticals
ALN-VSP